scholarly journals Clinical characteristics and outcomes of therapy-related chronic myelomonocytic leukemia

Blood ◽  
2013 ◽  
Vol 122 (16) ◽  
pp. 2807-2811 ◽  
Author(s):  
Koichi Takahashi ◽  
Naveen Pemmaraju ◽  
Paolo Strati ◽  
Graciela Nogueras-Gonzalez ◽  
Jing Ning ◽  
...  

Key Points t-CMML is associated with higher-risk cytogenetics and manifests poor prognosis. t-CMML should be recognized as one of the therapy-related myeloid neoplasms.

Blood ◽  
2013 ◽  
Vol 121 (12) ◽  
pp. 2186-2198 ◽  
Author(s):  
Raphaël Itzykson ◽  
Olivier Kosmider ◽  
Aline Renneville ◽  
Margot Morabito ◽  
Claude Preudhomme ◽  
...  

Key Points Early clonal dominance may distinguish chronic myelomonocytic leukemia from other chronic myeloid neoplasms with similar gene mutations. Early dominance of TET2-mutated cells in the hematopoietic tissue promotes myeloid differentiation skewing toward the granulomonocytic line.


Blood ◽  
2013 ◽  
Vol 121 (25) ◽  
pp. 5068-5077 ◽  
Author(s):  
Eric Padron ◽  
Jeffrey S. Painter ◽  
Sateesh Kunigal ◽  
Adam W. Mailloux ◽  
Kathy McGraw ◽  
...  

Key Points GM-CSF–dependent STAT5 hypersensitivity is detected in 90% of CMML samples and is enhanced by signaling mutations. Treatment with a GM-CSF–neutralizing antibody and JAK2 inhibitors reveals therapeutic potential.


2017 ◽  
Vol 1 (14) ◽  
pp. 972-979 ◽  
Author(s):  
Yanyan Zhang ◽  
Liang He ◽  
Dorothée Selimoglu-Buet ◽  
Chloe Jego ◽  
Margot Morabito ◽  
...  

Key Points Transgenic mice expressing 3 human cytokines enable expansion of CMML cells with limited stem cell engraftment. The mutational profile of CMML cells that expand in mice mirrors that of patient monocytes.


Blood ◽  
2015 ◽  
Vol 125 (23) ◽  
pp. 3618-3626 ◽  
Author(s):  
Dorothée Selimoglu-Buet ◽  
Orianne Wagner-Ballon ◽  
Véronique Saada ◽  
Valérie Bardet ◽  
Raphaël Itzykson ◽  
...  

Key Points An increase in the classical monocyte subset to >94% of total monocytes discriminates CMML from other monocytoses with high specificity. This characteristic increase in classical monocytes disappears in CMML patients who respond to hypomethylating agents.


2011 ◽  
Vol 125 (4) ◽  
pp. 242-246 ◽  
Author(s):  
Norimichi Hattori ◽  
Kunihiko Fukuchi ◽  
Tsuyoshi Nakamaki ◽  
Mayumi Homma ◽  
Hirotsugu Ariizumi ◽  
...  

2021 ◽  
Vol 2021 ◽  
pp. 1-6
Author(s):  
Heyang Zhang ◽  
Xiaoxue Wang ◽  
Shibo Li ◽  
Xianfu Wang ◽  
Xianglan Lu ◽  
...  

Double minute chromosomes (dmins) are a form of gene amplification presenting as small spherical paired chromatin bodies. Dmins are rare in hematologic malignancies and are generally associated with a poor prognosis. Some case reports identified MYC or MLL gene amplification performing as dmin in myeloid neoplasms. FLT3 (FMS-related tyrosine kinase 3) acts as an oncogene in myeloid neoplasms which is associated with several signal transduction pathways. Genomic amplification of FLT3 has not been reported in hematological disease. The current study attempts to demonstrate the existence of double minute chromosomes via FLT3 gene amplification in a patient diagnosed with chronic myelomonocytic leukemia (CMML). Routine G-banded karyotype, array-based comparative genomic hybridization, and fluorescence in situ hybridization analyses were used to characterize the cytogenetic abnormality in the patient’s bone marrow. FLT3 amplification as dmins in a patient with CMML was revealed. This case study reports a rare double minute chromosome via FLT3 amplification in CMML by using array-based comparative genomic hybridization and fluorescence in situ hybridization analyses. The study also proposed another possible mechanism of FLT3 genes in leukemogenesis.


Blood ◽  
2017 ◽  
Vol 129 (15) ◽  
pp. 2148-2160 ◽  
Author(s):  
Yuichiro Nakata ◽  
Takeshi Ueda ◽  
Akiko Nagamachi ◽  
Norimasa Yamasaki ◽  
Ken-ichiro Ikeda ◽  
...  

Key Points Acquired expression of CblQ367P induces sustained proliferation of myelomonocytes, multilineage dysplasia, and splenomegaly resembling CMML. Combined inhibition of PI3K and JAK2 efficiently suppressed the growth of CblQ367P-induced CMML cells.


2017 ◽  
Vol 31 (3) ◽  
pp. 429-441 ◽  
Author(s):  
Jennifer Chapman ◽  
Julia T Geyer ◽  
Mahsa Khanlari ◽  
Adrienne Moul ◽  
Carmen Casas ◽  
...  

2018 ◽  
Vol 2 (15) ◽  
pp. 1807-1816 ◽  
Author(s):  
Sanam Loghavi ◽  
Dawen Sui ◽  
Peng Wei ◽  
Guillermo Garcia-Manero ◽  
Sherry Pierce ◽  
...  

Key Points Validation of the WHO 2017 CMML categories supports distinguishing MP-CMML from MDS–CMML. The prognostic value of the new 3-tiered blast-based CMML stratification scheme is limited.


Sign in / Sign up

Export Citation Format

Share Document